Prospective Grant of Exclusive License: Insulin Producing Cells Differentiated From Non-Insulin Producing Cells by GLP-1 and Exendin-4 and Use Thereof; Correction
---
identifier: "/us/fr/00-27889"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Prospective Grant of Exclusive License: Insulin Producing Cells Differentiated From Non-Insulin Producing Cells by GLP-1 and Exendin-4 and Use Thereof; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "00-27889"
section_name: "Prospective Grant of Exclusive License: Insulin Producing Cells Differentiated From Non-Insulin Producing Cells by GLP-1 and Exendin-4 and Use Thereof; Correction"
positive_law: false
currency: "2000-10-31"
last_updated: "2000-10-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "00-27889"
document_type: "notice"
publication_date: "2000-10-31"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "65 FR 64980"
fr_volume: 65
---
# Prospective Grant of Exclusive License: Insulin Producing Cells Differentiated From Non-Insulin Producing Cells by GLP-1 and Exendin-4 and Use Thereof; Correction
The notice published in the October 17, 2000 *Federal Register* (65 FR 61352)—announcing the prospective grant of an exclusive license for use of insulin producing cells differentiated from non-insulin producing cells—incorrectly listed the PCT Patent Application Serial Number as “PCT/US99/180899” and the PHS Ref. as “E-151-97/1”. NIH is publishing this notice to correct the PCT application number to read “E-251-97/1”.
Dated: October 23, 2000.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of Technology Transfer.